Atlas Trials

Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis

Clinical trial NCT01981161 · COMPLETED

Trial details

NCT number
NCT01981161
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2013-11-19
Primary completion
2018-06-20
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.